Pharmacology of Potential Anti-Tumour Agents: Iron and Copper Chelators of the ApT, BpT and DpT Classes
Pharmacology of Potential Anti-Tumour Agents: Iron and Copper Chelators of the ApT, BpT and DpT Classes
批准号:
nhmrc : 1021607
负责人:
Dr David Lovejoy
金额:
$43.15万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2012
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2012-01-01 至 2015-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cancer cells take up more of the essential nutrients copper and iron than normal cells. Increased metabolism of these metals is linked to tumour growth progression. Our laboratory has developed compounds that bind these metals in tumours. Our studies suggest our novel compounds display a novel tumour targeting strategy which may explain their ability to also overcome drug resistance. This unique mechanism of action is crucial to understand for the development of novel anti-cancer agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Slowing progression of Alzheimer’s disease by modulating the kynurenine pathway
-
批准号:nhmrc : 1128849
-
项目类别:Project Grants
-
资助金额:$39.51万
-
财政年份:2017
-
负责人:Dr David Lovejoy
-
依托单位:
Pre-clinical Development of a Novel Second Generation Chemotherapeutic for Cancer Therapy
-
批准号:nhmrc : 1038660
-
项目类别:Development Grants
-
资助金额:$39.0万
-
财政年份:2012
-
负责人:Dr David Lovejoy
-
依托单位:
Investigating the Cellular Response to Iron-Depletion: The Trilogy of ASK1, Thioredoxin and Ribonucleotide Reductase
-
批准号:nhmrc : 1021601
-
项目类别:Project Grants
-
资助金额:$36.85万
-
财政年份:2012
-
负责人:Dr David Lovejoy
-
依托单位:
Toxicological and pre-clinical assessment of the anti-cancer compound Bp4eT
-
批准号:nhmrc : 571379
-
项目类别:NHMRC Development Grants
-
资助金额:$13.26万
-
财政年份:2009
-
负责人:Dr David Lovejoy
-
依托单位:
Examination of the Molecular Pharmacology of Anthracyclines Induced via their Interaction with Iron
-
批准号:nhmrc : 457310
-
项目类别:NHMRC Project Grants
-
资助金额:$41.24万
-
财政年份:2007
-
负责人:Dr David Lovejoy
-
依托单位:
国内基金
海外基金
Transient Receptor Potential 通道 A1在膀胱过度活动症发病机制中的作用
-
批准号:30801141
-
项目类别:青年科学基金项目
-
资助金额:28.0万元
-
批准年份:2008
-
负责人:都书琪
-
依托单位: